Evidence map›Paper›PMID 37863640›Full record

ArticleFEBS open bio2023

Three-dimensional, PEG-based hydrogels induce spheroid formation and enhance viability of A2058 melanoma cells.

Kata Nóra Enyedi, Gábor Enyedi, Eszter Lajkó

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Kata Nóra EnyediFaculty of Science, Institute of Chemistry, Eötvös Loránd University, Budapest, Hungary.ORCID 0000-0003-3724-5936
Gábor EnyediDepartment of Research and Development, En-Co Software Zrt., Budapest, Hungary.
Eszter LajkóDepartment of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary.ORCID 0000-0002-4796-4646
Eötvös Loránd University · HUNational Research, Development and Innovation Office · HUSemmelweis University · HU

Funding

Hungarian Scientific Research Fund PD_OTKA131794Semmelweis Science and Innovation Fund 126592/AOGEN/2021Semmelweis Science and Innovation Fund STIA-OTKA-2021
6 · The paper itself

Abstract

Traditional drug screening methods use monolayer (2D) tumor cell cultures, which lack basic features of tumor complexity. As an alternative, 3D hydrogels have begun to emerge as simple, time-, and cost-saving systems. One of the most promising candidates, synthetic alkoxysilane-PEG (polyethylene glycol)-based hydrogels, are formed by "sol-gel" polymerization in an aqueous medium, which allows control over the incorporated elements. Our aims were to optimize siloxane-PEG hydrogels for three different cell lines of skin origin and utilize these 3D hydrogels as a feasible drug (e.g., daunorubicin) screening assay. A drastic increase in survival and the formation of cellular aggregates (spheroids) could be observed in A2058 melanoma cells, but not in keratinocyte and endothelial cell lines. A deep-learning neural network was trained to recognize and distinguish between the cellular formations and allowed the fast processing of hundreds of microscopic images. We developed an artificial intelligence (AI)-assisted application (https://github.com/enyecz/CancerDetector2), which indicated that, in terms of average area of the spheroids treated with daunorubicin, A2058 melanoma cell 3D aggregates have better survival in a hydrogel containing 15% bis-mono-ethoxysilane-PEG.

Indexed as

MelanomaSpheroids, CellularArtificial IntelligenceDaunorubicinHumansHydrogelsDaunorubicinHydrogelsartificial intelligencecancerhydrogelmelanomapolyethylene glycolspheroids

Identifiers

PMID37863640
PMCPMC10699105
OpenAlexW4387801529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.